Joel Greenblatt's HCA Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 49,212 shares of HCA Healthcare, Inc. (HCA) worth $22.98 M, representing 0.08% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 49 quarters.
Based on 13F filings since 2013, Joel Greenblatt has maintained a long-term strategic position in HCA, representing a significant commitment to this investment thesis. Largest addition occurred in Q1 2016, adding 374,893 shares. Largest reduction occurred in Q3 2016, reducing 537,278 shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's HCA Healthcare (HCA) Holding Value Over Time
Track share changes against reported price movement
Quarterly HCA Healthcare (HCA) Trades by Joel Greenblatt
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +25,597 | Add 108.39% | 49,212 | $466.86 |
| Q3 2025 | +16,193 | Add 218.18% | 23,615 | $426.20 |
| Q2 2025 | -460 | Reduce 5.84% | 7,422 | $383.10 |
| Q1 2025 | -13,524 | Reduce 63.18% | 7,882 | $345.55 |
| Q4 2024 | -924 | Reduce 4.14% | 21,406 | $300.15 |
| Q3 2024 | +224 | Add 1.01% | 22,330 | $406.43 |
| Q2 2024 | -1,053 | Reduce 4.55% | 22,106 | $321.28 |
| Q1 2024 | +8,849 | Add 61.84% | 23,159 | $333.53 |
| Q4 2023 | -10,018 | Reduce 41.18% | 14,310 | $270.68 |
| Q3 2023 | +565 | Add 2.38% | 24,328 | $245.98 |
| Q2 2023 | -3,088 | Reduce 11.50% | 23,763 | $303.48 |
| Q1 2023 | +6,344 | Add 30.94% | 26,851 | $263.68 |
| Q4 2022 | +7,218 | Add 54.32% | 20,507 | $239.96 |
| Q3 2022 | -8,154 | Reduce 38.03% | 13,289 | $183.76 |
| Q2 2022 | -6,109 | Reduce 22.17% | 21,443 | $168.07 |
| Q1 2022 | -7,106 | Reduce 20.50% | 27,552 | $250.62 |
| Q4 2021 | +176 | Add 0.51% | 34,658 | $256.91 |
| Q3 2021 | -1,088 | Reduce 3.06% | 34,482 | $242.71 |
| Q2 2021 | +9,849 | Add 38.29% | 35,570 | $206.75 |
| Q1 2021 | +30 | Add 0.12% | 25,721 | $188.33 |
| Q4 2020 | -6,580 | Reduce 20.39% | 25,691 | $164.45 |
| Q3 2020 | +15,554 | Add 93.04% | 32,271 | $124.69 |
| Q2 2020 | -25,802 | Reduce 60.68% | 16,717 | $97.09 |
| Q1 2020 | +26,957 | Add 173.22% | 42,519 | $89.84 |
| Q4 2019 | +15,562 | New Buy | 15,562 | $147.80 |
| Q3 2019 | -10,693 | Sold Out | 0 | $0.00 |
| Q2 2019 | -238,777 | Reduce 95.71% | 10,693 | $135.14 |
| Q1 2019 | +36,176 | Add 16.96% | 249,470 | $130.38 |
| Q4 2018 | -5,305 | Reduce 2.43% | 213,294 | $124.45 |
| Q3 2018 | +113,775 | Add 108.54% | 218,599 | $139.12 |
| Q2 2018 | +104,824 | New Buy | 104,824 | $102.60 |
| Q4 2017 | -327,576 | Sold Out | 0 | $0.00 |
| Q3 2017 | -11,763 | Reduce 3.47% | 327,576 | $79.59 |
| Q2 2017 | +13,650 | Add 4.19% | 339,339 | $87.20 |
| Q1 2017 | +208,745 | Add 178.50% | 325,689 | $88.99 |
| Q4 2016 | -262,448 | Reduce 69.18% | 116,944 | $74.02 |
| Q3 2016 | -537,278 | Reduce 58.61% | 379,392 | $75.63 |
| Q2 2016 | +294,438 | Add 47.32% | 916,670 | $77.01 |
| Q1 2016 | +374,893 | Add 151.57% | 622,232 | $78.05 |
| Q4 2015 | +247,339 | New Buy | 247,339 | $67.63 |
| Q3 2015 | -25,396 | Sold Out | 0 | $0.00 |
| Q2 2015 | +25,396 | New Buy | 25,396 | $90.72 |
| Q4 2014 | -3,699 | Sold Out | 0 | $0.00 |
| Q3 2014 | -21,519 | Reduce 85.33% | 3,699 | $70.56 |
| Q2 2014 | -8,336 | Reduce 24.84% | 25,218 | $56.39 |
| Q1 2014 | -105,445 | Reduce 75.86% | 33,554 | $52.51 |
| Q4 2013 | +80,245 | Add 136.58% | 138,999 | $47.71 |
| Q3 2013 | -68,188 | Reduce 53.72% | 58,754 | $42.75 |
| Q2 2013 | +126,942 | Add 0.00% | 126,942 | $36.06 |
Joel Greenblatt's HCA Healthcare Investment FAQs
Joel Greenblatt first purchased HCA Healthcare, Inc. (HCA) in Q2 2013, acquiring 126,942 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held HCA Healthcare, Inc. (HCA) for 49 quarters since Q2 2013.
Joel Greenblatt's largest addition to HCA Healthcare, Inc. (HCA) was in Q1 2016, adding 622,232 shares worth $48.56 M.
According to the latest 13F filing for Q4 2025, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 49,212 shares of HCA Healthcare, Inc. (HCA), valued at approximately $22.98 M.
As of the Q4 2025 filing, HCA Healthcare, Inc. (HCA) represents approximately 0.08% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.
Joel Greenblatt's peak holding in HCA Healthcare, Inc. (HCA) was 916,670 shares, as reported at the end of Q2 2016.